⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLX News
Telix Pharmaceuticals Limited American Depositary Shares
ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026
globenewswire.com
TLX
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
globenewswire.com
TLX
Telix Successfully Prices and Upsizes US$600 Million Convertible Bonds USA - English APAC - English
prnewswire.com
TLX
Telix Refinances Convertible Bonds USA - English APAC - English
prnewswire.com
TLX
Telix and Regeneron Announce Strategic Radiopharma Collaboration
globenewswire.com
REGN
TLX
Regeneron and Telix Announce Strategic Radiopharma Collaboration
globenewswire.com
REGN
TLX
FDA Accepts NDA for TLX101-Px (Pixclara®)
globenewswire.com
TLX
Telix Strengthens Board with Additional Director Appointments
globenewswire.com
TLX
Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement
globenewswire.com
TLX
Telix Appoints David Gill as Non-Executive Director
globenewswire.com
TLX
EOLS